首页> 外文期刊>Molecular pharmaceutics >Effect of Common Excipients on Intestinal Drug Absorption in Wistar Rats
【24h】

Effect of Common Excipients on Intestinal Drug Absorption in Wistar Rats

机译:常见赋形剂对Wistar大鼠肠道药物吸收的影响

获取原文
获取原文并翻译 | 示例
           

摘要

The aim of the present paper is to study the effect of common excipients on the permeability of atenolol (as drug absorbed mainly by passive diffusion) and rhodamine (as P-glycoprotein substrate). The apparent permeability was measured by an in situ perfusion method in Wistar rats using the dosed loop Doluisio's method. Permeability values were characterized in the absence and presence of 18 commonly used excipients. Excipient concentrations were selected based on the amounts in oral immediate release dosage forms, which failed the test during the human bioequivalence studies. Atenolol was studied with and without excipients in the whole small intestine, whereas rhodamine was tested in three different intestinal segments to account for the differential expression of P-glycoprotein, and it was further on tested in the ileum, in the presence of excipients. Atenolol presented higher permeability values when it was administered with colloidal silica, croscarmellose, hydroxypropyl methylcellulose (HPMC), magnesium stearate, MgCO3, poly(ethylene glycol) 400, poly(vinylpyrrolidone), sorbitol, starch, and TiO2 rhodamine showed higher permeability values when it was administered with croscarmellose and HPMC. On the one hand, the mechanisms of action were not discernible with the proposed experiments. On the other hand, commercial formulations do not present a single excipient but several, which can counteract their effects. The in situ perfusion technique can be useful for a preliminary screening and risk analysis, while the in vivo pharmacokinetic results would be needed to define conclusive effects.
机译:本文的目的是研究常见赋形剂对阿绿洛尔的渗透率的影响(作为主要由被动扩散的药物吸收)和罗丹明(作为P-糖蛋白基质)。使用令人染色的环Doluisio的方法,通过Wistar大鼠中的原位灌注方法测量表观渗透性。在缺乏和存在的18种常用赋形剂的情况下表征了渗透率值。基于口腔立即释放剂型的量选择赋形剂浓度,这在人生物等效研究期间失败了测试。在整个小肠中使用和没有赋形剂进行了研究,而罗丹明在三个不同的肠段中测试以考虑p-糖蛋白的差异表达,并且在赋形剂存在下进一步在回肠中测试。当用胶体二氧化硅,Croscarlose,羟丙基甲基纤维素(HPMC),硬脂酸镁,MgCO 3,聚(乙二醇)400,聚(乙烯基吡咯烷酮),山梨糖醇,淀粉和TiO 2罗丹明时,当胶质纤维素羧烷基甲基纤维素(HPMC),氟烷醇糖醇,淀粉和TiO 2罗丹明时,当较高的渗透率值呈现更高的渗透率值它用Croscarmellose和HPMC施用。一方面,随着所提出的实验,不可辨别的作用机制。另一方面,商业制剂不呈现单一赋形剂,而且可以抵消它们的效果。原位灌注技术可用于初步筛选和风险分析,而在体内药代动力学结果中将是需要定义确凿的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号